Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
03/1996
03/21/1996WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/21/1996WO1996008228A2 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
03/21/1996CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996CA2199484A1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
03/20/1996EP0702013A2 Imidazopyridines
03/20/1996EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists
03/20/1996EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent
03/20/1996EP0701819A2 Novel compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
03/20/1996CN1119014A Benzopyranes as potassium channel openers
03/20/1996CN1119013A Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions
03/20/1996CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines
03/20/1996CN1031339C Process for preparation of heterocyclically substituted phenylacetic acid derivatives
03/19/1996US5500429 Cardiovascular
03/19/1996US5500222 Mixed with monoglyceride permeation enhancer
03/16/1996CA2158225A1 Imidazopyridines
03/14/1996WO1996007658A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE
03/14/1996WO1996007653A1 Endothelin receptor antagonists
03/14/1996WO1996007426A1 Enteral vaccine for vaginal infections
03/14/1996CA2199255A1 Enteral vaccine for vaginal infections
03/13/1996EP0700904A1 Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicaments containing them as well as intermediates for their preparation
03/13/1996EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them
03/13/1996EP0700383A1 Novel 1-phenylalkanone 5-ht 4? receptor ligands
03/13/1996EP0700293A1 Dihydrotestosterone for use in androgenotherapy
03/13/1996EP0700284A1 Controlled release oxybutynin formulations
03/13/1996CN1118347A Benzotoudened 5-ringneterocycl, preparation and phamaceutical and diagnostic use of same
03/13/1996CA2157998A1 Pharmaceutical compounds
03/12/1996US5498722 Hypotensives
03/12/1996US5498598 Composition for nasal administration of desmopressin
03/07/1996WO1996006937A1 Improvements in production of proteins in host cells
03/07/1996WO1996006845A1 Substituted 9-alkyladenines
03/07/1996WO1996006840A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/07/1996WO1996006606A1 Dihydro-2,3-benzodiazepine derivatives
03/07/1996CA2198345A1 Improvements in production of proteins in host cells
03/07/1996CA2197895A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/06/1996EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof
03/06/1996EP0699204A1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate
03/06/1996EP0699191A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/06/1996EP0699185A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS
03/06/1996EP0699069A1 Endothelin receptor antagonists
03/06/1996CN1117960A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
03/06/1996CN1117873A Usage of follicle-stimulating hormone
03/05/1996US5496823 Administering propentofylline or a salt thereof to a patient
03/05/1996US5496807 Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it
03/05/1996US5496556 Administering a steroid reductase inhibiting compound, an androstene derivative
02/1996
02/29/1996WO1996005837A1 Use of n-substituted phenothiazines
02/29/1996WO1996005835A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure
02/29/1996WO1996005833A1 Methods of inhibiting endometrial cancer
02/29/1996WO1996005832A1 Methods of inhibiting primary endometrial hyperplasia
02/29/1996DE4430091A1 Verwendung von N-substituierten Phenothiazinen Use of N-substituted phenothiazines
02/29/1996CA2198256A1 Use of n-substituted phenothiazines
02/29/1996CA2198120A1 Methods of inhibiting primary endometrial hyperplasia
02/29/1996CA2198119A1 Methods of inhibiting endometrial cancer
02/29/1996CA2198090A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure
02/28/1996EP0698614A1 Endothelin-antagonizing peptide
02/28/1996EP0698094A1 Bmp-11 compositions
02/28/1996EP0698040A1 Lhrh antagonists
02/28/1996EP0698020A1 Pyrimidine derivatives
02/28/1996EP0697880A1 Inhibition of leukocyte adhesion
02/28/1996EP0697873A1 Olefin-substituted long chain compounds
02/28/1996CN1117484A Fatty acid derivatives
02/27/1996US5495021 Benzo[f]quinolinones
02/27/1996US5494670 Method of treating ketosis
02/27/1996CA2155447A1 Substituted biphenyl isoxazole sulfonamides
02/22/1996WO1996005221A1 Calcitonin receptor
02/22/1996WO1996005193A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists
02/22/1996WO1996004930A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs
02/22/1996WO1996004928A1 Calcitonin gene related peptide receptor
02/22/1996WO1996004905A1 Phenoxyphenylacetic acid derivatives
02/22/1996CA2195758A1 Phenoxyphenylacetic acid derivatives
02/21/1996EP0697410A1 54-substituted alkylidene 2-(N-cyanoimino)-thiazolidin-4-one derivatives, their preparation and their use as aldose reductase inhibitors
02/21/1996EP0696919A1 Diagnosis and treatment of erectile dysfunction
02/21/1996EP0479903B1 Substituted imidazoles useful as angiotensin ii blockers
02/21/1996CN1117045A Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them
02/21/1996CN1117044A Substituted N-heteroaroaroylguanidin, preparation, pharmaceutical application and medicine containg same
02/21/1996CN1116937A Chinese herb medicine preparation for treating prostate hyperplasia and its preparing method
02/21/1996CN1031051C Cycloalkyl-substituted glutaramide antihypertensive agents
02/20/1996US5492923 Drug for treating arterial hypertension and atherosclerosis
02/20/1996US5492921 Preventing restenosis
02/20/1996US5492713 Nutriment preparation
02/15/1996WO1996004276A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
02/15/1996WO1996004275A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
02/15/1996WO1996004250A1 Benzimidazole derivatives having dopaminergic activity
02/15/1996WO1996004241A2 Benzoylguanidine derivatives as medicaments
02/15/1996WO1995031991A3 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
02/15/1996CA2196763A1 Benzoylguanidine derivatives as medicaments
02/15/1996CA2196219A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
02/15/1996CA2196218A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
02/14/1996EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels
02/14/1996EP0696455A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs
02/14/1996CN1116524A Formes galeniques a liberation prolongee du chlorhydrate d'alfuzosine
02/13/1996US5491142 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
02/13/1996US5491141 Enzyme inhibitors, hypertensive agents; treating diuretic, congestive heart failure, aldosteronism, renal diseases, glaucoma
02/13/1996US5491132 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same
02/08/1996WO1996003399A1 Dihydrobenzofuranes
02/08/1996WO1996003143A1 Methods for treating bleeding disorders
02/08/1996WO1996003140A1 HLA binding peptides and their uses
02/08/1996WO1996003138A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
02/08/1996WO1996003130A1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri
02/08/1996CA2195671A1 Hla binding peptides and their uses
02/07/1996EP0695309A1 Oxytocin antagonist